Evidence Synthesis
Newgen (NEWGEN) Sees a Significant Improvement in Gross Margin, Despite a Decline in Daily Volume and Revenue Growth.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 15 Sept 2026, 03:49
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Newgen (NEWGEN) Sees a Significant Improvement in Gross Margin, Despite a Decline in Daily Volume and Revenue Growth.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 53.37 % | 13.09 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 13.09 % | 19.48 | ▼ |
| REVENUE_GROWTH_YOY | 11.2 % | 27.8 | ▼ |
| EPS_ACTUAL | 5.69 INR | 6.286 | ▼ |
| EPS_SURPRISE_PERCENT | 0.225 % | -0.025 | ▲ |
| PRICE_CHANGE_PERCENT | -0.984 % | — | - |
| DAILY_VOLUME | 5,83,926 shares | 28,62,351 | ▼ |
| CLOSE_PRICE | 502.9 INR | 507.9 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.67 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 4 | ▼ |
| TARGET_PRICE_PREMIUM | 22.29 % | — | - |